Cardiology Practice Questions

Q: In patients with suspected acute coronary syndrome, which biomarker is the most reliable for early diagnosis?

Troponin. ***Troponin*** - **Cardiac troponins (cTnI and cTnT)** are highly specific and sensitive biomarkers for myocardial injury, released into the bloodstream within 2-4 hours of damage [1], [2]. - Their prolonged elevation, typically lasting several days, makes them the **most reliable marker** for diagnosing acute coronary syndrome (ACS) [1], [3]. *C-reactive protein* - **C-reactive protein (CRP)** is an acute-phase reactant indicative of systemic inflammation, which can be elevated in many conditions, not just ACS. - While elevated CRP levels are associated with increased risk of cardiovascular events, it is **not specific enough** for the early diagnosis of acute myocardial injury. *Serum cholesterol* - **Serum cholesterol** levels reflect long-term cardiovascular risk and are critically important in the prevention and management of atherosclerosis. - They do not change rapidly enough during an acute event to be useful in the **early diagnosis of ACS**. *Myoglobin* - **Myoglobin** is an early marker of muscle damage, including cardiac muscle, and can rise within 1-2 hours of myocardial infarction. - However, its **lack of cardiac specificity** (also present in skeletal muscle) and rapid clearance from the bloodstream limit its diagnostic utility compared to troponin.

Q: A 45-year-old male presents with acute shortness of breath and chest pain. An ECG reveals ST elevation in leads V1 to V4. Which coronary artery is most likely occluded?

Left anterior descending artery. *Left anterior descending artery* - **ST elevation** in leads **V1 to V4** indicates an **anterior myocardial infarction** [1]. - The **left anterior descending (LAD) artery** supplies the **anterior wall of the left ventricle** and the anterior two-thirds of the septum [2]. *Right coronary artery* - Occlusion of the **right coronary artery (RCA)** typically causes **inferior myocardial infarctions**, reflected by ST elevation in leads **II, III, and aVF**. - It often supplies the **right ventricle**, inferior wall of the left ventricle, and the atrioventricular (AV) node. *Left circumflex artery* - Occlusion of the **left circumflex artery (LCX)** usually leads to **lateral or posterior myocardial infarctions**, with ST elevation in leads **I, aVL, V5, V6** or **ST depression in V1-V3** (posterior MI). - It supplies the **lateral and posterior walls of the left ventricle**. *Posterior descending artery* - The **posterior descending artery (PDA)** is typically a branch of the RCA (in 85% of individuals) and supplies the **inferior-posterior wall of the left ventricle** and the posterior third of the interventricular septum. - Occlusion of the PDA, whether from the RCA or LCX, would primarily cause an **inferior or inferoposterior MI**, not anterior, with ECG changes in leads **II, III, aVF**, and potentially **V7-V9**.

Q: Which of the following risk factors is most strongly associated with the development of embolic stroke in atrial fibrillation?

Previous stroke. ***Previous stroke*** - A history of **prior ischemic stroke or transient ischemic attack (TIA)** is the strongest independent predictor of future embolic stroke in patients with **atrial fibrillation (AF)**. - This risk factor is weighted heavily in stroke risk stratification scores like **CHA2DS2-VASc** (2 points for previous stroke/TIA). *Hypertension* - **Hypertension** is a significant risk factor for stroke in general and contributes to cardiovascular morbidity. - However, its association with *embolic stroke specifically in the context of AF* is less potent compared to a **prior stroke**. *Diabetes mellitus* - **Diabetes mellitus** increases the overall risk of stroke and is an important cardiovascular risk factor. - While it contributes to the risk of stroke in AF, its predictive power for *embolic stroke* is secondary to a **previous thrombotic event**. *Coronary artery disease* - **Coronary artery disease (CAD)** often coexists with AF and shares common risk factors, contributing to overall cardiovascular risk. - While CAD indicates systemic vascular disease, it is **not as direct a predictor** of *embolic stroke from AF* as a previous embolic event.

Q: A 65-year-old man presents with palpitations and is found to have atrial fibrillation. What is the primary goal of therapy for this patient?

Anticoagulation. ***Anticoagulation*** - The primary goal in a patient with new-onset atrial fibrillation is to prevent **thromboembolic events**, particularly **stroke**, which can be devastating. [1] - While rate and rhythm control are important, addressing the **risk of clot formation** in the atria due to the irregular rhythm is the most immediate and critical priority for patient safety. [1] *Rate control* - This strategy aims to **slow the ventricular response** to atrial fibrillation to a more physiological rate, typically reducing symptoms like palpitations and improving cardiac output. [1] - While important for symptom management and preventing **tachycardia-induced cardiomyopathy**, it does not directly address the increased risk of stroke. [1] *Rhythm control* - This approach aims to restore and maintain **normal sinus rhythm**, which can alleviate symptoms and potentially improve cardiac function. [1] - While desirable, rhythm control carries its own risks (e.g., from antiarrhythmic drugs or procedures) and has not consistently shown superior outcomes over rate control in preventing stroke when adequate anticoagulation is used. *Cardioversion* - This procedure uses an electrical shock or medication to **convert atrial fibrillation back to normal sinus rhythm**. - While sometimes necessary, particularly in hemodynamically unstable patients, it is often performed after a period of anticoagulation to reduce the risk of thromboembolic events associated with the conversion process itself.

Q: A patient presents with acute myocardial infarction and a history of severe chest pain. Which anatomical area of the heart is most commonly affected in such cases?

Left ventricle. Left ventricle - The **left ventricle** has the largest muscle mass and performs the most work, making it particularly vulnerable to **ischemic injury** during myocardial infarction. - Due to the high **oxygen demand** and pressure workload, the left ventricle is the most common site of **myocardial infarction** [2]. *Right ventricle* - While the right ventricle can be affected, **right ventricular infarction** is less common and typically occurs secondary to **inferior wall myocardial infarction** affecting the left ventricle [1]. - Symptoms usually include **hypotension** and **jugular venous distention**, which are not universally present in all acute MIs. *Left atrium* - The **left atrium** primarily serves as a reservoir for blood and has a relatively small muscle mass, making isolated **left atrial infarction** extremely rare. - Infarction of the left atrium is usually asymptomatic and clinically insignificant compared to ventricular involvement. *Right atrium* - Similar to the left atrium, the **right atrium** has a small muscle mass and a lower metabolic demand, making it an uncommon site for infarction. - Isolated **right atrial infarction** is exceptionally rare and often found incidentally during autopsy in extensive myocardial infarctions.

Q: What is the primary concern for a patient with third-degree heart block?

Decreased heart rate. ***Decreased heart rate*** - In a **third-degree heart block**, there is a complete **disassociation between atrial and ventricular activity**, meaning no impulses from the atria reach the ventricles [2]. - The ventricles fire independently at a very slow escape rhythm (typically 20-40 bpm), leading to significant **bradycardia** and reduced cardiac output [1]. *Increased heart rate* - An increased heart rate, or **tachycardia**, is not characteristic of third-degree heart block [1]. - The block prevents rapid atrial impulses from being conducted to the ventricles. *Fluctuating heart rate* - While the heart rate can be variable with certain arrhythmias, a third-degree heart block typically presents with a **persistently slow and regular ventricular escape rhythm**, rather than wide fluctuations. - The heart rate is consistently low due to the complete block [1]. *Irregular heart rhythm* - Although there is **AV dissociation**, the ventricular rhythm in a third-degree heart block is often **regular but slow**, due to the consistent firing of an escape pacemaker [2]. - Increased irregularity might suggest a co-existing arrhythmia but is not the primary issue in complete heart block itself.

Q: What is the most appropriate initial management for a 65-year-old male with ST-elevation myocardial infarction (STEMI) presenting with crushing chest pain and diaphoresis?

Immediate PCI to restore coronary perfusion. ***Immediate PCI to restore coronary perfusion*** - For **STEMI**, the primary goal is to **promptly restore blood flow** to the ischemic myocardium. **Primary percutaneous coronary intervention (PCI)** is the preferred reperfusion strategy, ideally performed within **90 minutes** of first medical contact [2]. - PCI directly opens the occluded coronary artery, significantly reducing **infarct size**, improving ventricular function, and lowering mortality [2]. *Thrombolysis followed by transfer for PCI* - **Thrombolysis** is an alternative when primary PCI is not available within recommended timelines (e.g., if transfer to a PCI-capable center would take too long) [2]. - However, if PCI is readily available, it is **superior to thrombolysis** due to higher rates of successful reperfusion and lower rates of reocclusion and bleeding complications [2]. *Delayed PCI after medical stabilization* - Delaying reperfusion therapy in STEMI is **contraindicated**, as **time is myocardium**. Rapid reperfusion is critical to preserve myocardial tissue and improve patient outcomes. - Medical stabilization alone without reperfusion therapy is insufficient to address the underlying occluded coronary artery. *Medical management with antiplatelets and anticoagulants* - **Antiplatelet (e.g., aspirin, P2Y12 inhibitors)** and **anticoagulant (e.g., heparin)** therapies are crucial adjuncts to reperfusion in STEMI, helping to prevent further clot formation and stabilize the plaque [2]. - However, these medications alone cannot effectively open a fully occluded artery characteristic of STEMI [1]; **mechanical reperfusion (PCI)** or **pharmacological reperfusion (thrombolysis)** is required.

Q: A 62-year-old man with type 2 diabetes and a history of myocardial infarction is being treated for heart failure with reduced ejection fraction (HFrEF). According to the latest guidelines, which of the following medications should be added to optimize his treatment?

Sodium-glucose cotransporter-2 (SGLT2) inhibitor. ***Sodium-glucose cotransporter-2 (SGLT2) inhibitor*** * **SGLT2 inhibitors** are now recommended as a foundational therapy for HFrEF, regardless of diabetes status, due to their proven benefits in reducing **cardiovascular death** and **heart failure hospitalizations**. * In this patient with **type 2 diabetes** and **HFrEF**, an SGLT2 inhibitor would provide both glycemic control and significant cardiovascular protection. * *Sacubitril/valsartan* * **Sacubitril/valsartan** is a neprilysin inhibitor/angiotensin receptor blocker (ARNI) that is a cornerstone of HFrEF treatment, often replacing an **ACE inhibitor** or **ARB** [1]. * However, the question asks which medication *should be added* to *optimize* treatment, implying other foundational therapies might already be in place, and SGLT2 inhibitors offer an additional, distinct benefit. * *Ivabradine* * **Ivabradine** is indicated for HFrEF patients who are in **sinus rhythm** with a resting heart rate ≥ 70 bpm despite being on maximally tolerated doses of **beta-blockers**, to further reduce hospitalizations [1]. * The question does not provide information about his sinus rhythm or heart rate, or current beta-blocker status. * *Digoxin* * **Digoxin** may be considered in patients with HFrEF to reduce **heart failure hospitalizations**, particularly in those with **atrial fibrillation** or persistent symptoms despite optimal guideline-directed medical therapy [1]. * It does not improve survival in HFrEF and is generally reserved for patients who remain symptomatic after other foundational therapies.

Q: Identify the primary drug used for pharmacological stress testing in echocardiography.

Dobutamine. ***Dobutamine*** - **Dobutamine** is a synthetic catecholamine that stimulates beta-1 adrenergic receptors, increasing **myocardial contractility** and **heart rate**, thereby mimicking the effects of exercise. - It is the most commonly used pharmacological agent for **stress echocardiography** to evaluate for inducible **myocardial ischemia**. *Adenosine* - **Adenosine** is primarily used for **pharmacological stress testing** in **myocardial perfusion imaging (MPI)**, not typically for echocardiography. - It causes **coronary vasodilation**, leading to increased blood flow in healthy vessels, while stenotic vessels cannot dilate, highlighting relative perfusion differences. *Atropine* - **Atropine** is an **anticholinergic drug** used to increase heart rate when the target heart rate is not achieved with dobutamine alone during stress echocardiography. - It is an **adjunct** or **secondary agent**, not the primary drug, for inducing stress. *Diltiazem* - **Diltiazem** is a **calcium channel blocker** used to treat **hypertension** and **angina**, typically decreasing heart rate and myocardial oxygen demand. - It is an **anti-ischemic drug** and would counteract the purpose of a **stress test**, which is to induce and unmask ischemia.

Q: A 50-year-old male with severe hypertension and a history of headaches presents for evaluation. Which physiological phenomenon is most likely increased in this patient?

Systemic vascular resistance. - Severe **hypertension** is primarily characterized by chronically elevated **systemic vascular resistance (SVR)**, reflecting constricted arterioles. [2] - This increased resistance forces the heart to pump harder, leading to higher blood pressure, which can cause symptoms like **headaches**. *Renal plasma flow* - In chronic severe hypertension, **renal arterioles** may constrict, leading to a **decrease** in renal plasma flow rather than an increase. [2] - Reduced renal plasma flow can contribute to kidney damage over time. *Capillary hydrostatic pressure* - While overall blood pressure is elevated, the **capillary hydrostatic pressure** specifically within the systemic capillary beds may not be uniformly or significantly increased across all tissues. [1] - Capillary pressure is more strongly influenced by local regulatory mechanisms and venular tone than by systemic arterial pressure in many cases. *Glomerular filtration rate* - Initially, the **glomerular filtration rate (GFR)** might be maintained through autoregulation, but in severe and prolonged hypertension, renal damage can lead to a **decrease** in GFR. - Sustained high pressures can damage the **glomeruli**, impairing their filtering capacity.

Question 1

In patients with suspected acute coronary syndrome, which biomarker is the most reliable for early diagnosis?

Accepted Answer

Troponin

Answer

C-reactive protein

Answer

Serum cholesterol

Answer

Myoglobin

Question 2

A 45-year-old male presents with acute shortness of breath and chest pain. An ECG reveals ST elevation in leads V1 to V4. Which coronary artery is most likely occluded?

Accepted Answer

Left anterior descending artery

Answer

Right coronary artery

Answer

Left circumflex artery

Answer

Posterior descending artery

Question 3

Which of the following risk factors is most strongly associated with the development of embolic stroke in atrial fibrillation?

Accepted Answer

Previous stroke

Answer

Hypertension

Answer

Diabetes mellitus

Answer

Coronary artery disease

Question 4

A 65-year-old man presents with palpitations and is found to have atrial fibrillation. What is the primary goal of therapy for this patient?

Accepted Answer

Anticoagulation

Answer

Rate control

Answer

Rhythm control

Answer

Cardioversion

Question 5

A patient presents with acute myocardial infarction and a history of severe chest pain. Which anatomical area of the heart is most commonly affected in such cases?

Accepted Answer

Left ventricle

Answer

Right ventricle

Answer

Left atrium

Answer

Right atrium

Question 6

What is the primary concern for a patient with third-degree heart block?

Accepted Answer

Decreased heart rate

Answer

Increased heart rate

Answer

Fluctuating heart rate

Answer

Irregular heart rhythm

Question 7

What is the most appropriate initial management for a 65-year-old male with ST-elevation myocardial infarction (STEMI) presenting with crushing chest pain and diaphoresis?

Accepted Answer

Immediate PCI to restore coronary perfusion

Answer

Thrombolysis followed by transfer for PCI

Answer

Delayed PCI after medical stabilization

Answer

Medical management with antiplatelets and anticoagulants

Question 8

A 62-year-old man with type 2 diabetes and a history of myocardial infarction is being treated for heart failure with reduced ejection fraction (HFrEF). According to the latest guidelines, which of the following medications should be added to optimize his treatment?

Accepted Answer

Sodium-glucose cotransporter-2 (SGLT2) inhibitor

Answer

Sacubitril/valsartan

Answer

Ivabradine

Answer

Digoxin

Question 9

Identify the primary drug used for pharmacological stress testing in echocardiography.

Accepted Answer

Dobutamine

Answer

Adenosine

Answer

Atropine

Answer

Diltiazem

Question 10

A 50-year-old male with severe hypertension and a history of headaches presents for evaluation. Which physiological phenomenon is most likely increased in this patient?

Accepted Answer

Systemic vascular resistance

Answer

Renal plasma flow

Answer

Capillary hydrostatic pressure

Answer

Glomerular filtration rate

Cardiology — MCQs

Cardiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?